To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Social Welfare.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title; table of contents This Act may be cited as the Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2023 or the...
- Section id1876f17d70834b1cb2f0b41a6d1708a5: 2. Continuing support for research on endemic fungal diseases The Public Health Service Act is amended by inserting after section 447D of such Act (42 U.S.C....
- Section id04d36708edf445018ede29123a4815cd: 447E. Endemic fungal diseases The Director of the Institute shall— continue to conduct or support basic, translational, and clinical research related to fungal...
- Section id31CEF12DD45F485B8809681105CADFF8: 3. Endemic fungal disease working group The Secretary of Health and Human Services (referred to in this section as the Secretary) shall establish a working...
- Section id201b85c13c8f482cab30a403528fedea: 4. Expanding tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis Section 524(a)(3) of the...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Social Welfare
Primary Purpose
This bill, To support endemic fungal disease research, incentivize fungal vaccine development, discover new antifungal therapies and diagnostics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Mark Kelly
D-AZ | Primary Sponsor
Legislative Progress
IntroducedMr. Kelly (for himself and Ms. Sinema) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology